Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Sodium Phosphate, Dibasic And Sodium Phosphate, Monobasic, Unspecified Form
Brand Name
Sunmark Saline Single
Generic Name
Sodium Phosphate, Dibasic And Sodium Phosphate, Monobasic, Unspecified Form
Active Ingredient
Sodium Phosphate, Dibasic, Unspecified FormCategory
Other
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 7 g/118mL | ENEMA | RECTAL | 49348-186 |
Detailed information about Sunmark Saline Single
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Sunmark Saline Single, you must consult a qualified healthcare professional.
Sodium Phosphate, Dibasic is a multifunctional pharmacological agent used primarily as an osmotic laxative for bowel preparation and as an electrolyte replenisher to treat or prevent hypophosphatemia.
Dosage for Sodium Phosphate, Dibasic is highly individualized and depends strictly on the indication and the patient's baseline electrolyte levels.
For colonoscopy preparation using oral tablets, a typical regimen may involve 32 tablets (each containing a combination of monobasic and dibasic sodium phosphate) taken in divided doses. For example, 4 tablets every 15 minutes with 8 ounces of clear liquid for a total of 20 tablets on the evening before the procedure, followed by 12 tablets on the morning of the procedure. If using an oral solution, a common dose is 15-45 mL diluted in water, though many clinicians have moved away from high-dose oral phosphate solutions due to safety concerns.
For mild to moderate hypophosphatemia, oral doses of 250 mg to 500 mg of phosphorus (as phosphate salts) are typically given 3 to 4 times daily. For severe hypophosphatemia (serum phosphorus < 1.0 mg/dL), intravenous doses of 0.08 to 0.24 mmol/kg of body weight may be infused over 6 to 12 hours, with frequent monitoring of serum levels.
Sodium Phosphate, Dibasic must be used with extreme caution in children. For constipation in children aged 5 to 11, a rectal enema (half the adult dose) may be used under medical supervision. Oral phosphate for bowel prep is generally NOT recommended for children under the age of 18 due to the high risk of severe electrolyte shifts and dehydration. Always consult a pediatric specialist for precise weight-based dosing.
Sodium Phosphate, Dibasic is contraindicated (should not be used) in patients with significant renal impairment (creatinine clearance < 30 mL/min). In patients with mild to moderate impairment, doses must be significantly reduced, and phosphorus levels must be monitored every few hours during treatment.
No specific dose adjustments are usually required for liver disease, as the drug is cleared renally. However, patients with cirrhosis and ascites are at higher risk for fluid imbalances and should be monitored closely.
Patients over age 65 are at a significantly higher risk for acute phosphate nephropathy (kidney damage). Healthcare providers typically use the lowest effective dose and ensure the patient is aggressively hydrated before, during, and after administration.
If you miss a dose during a bowel preparation regimen, contact your doctor's office immediately. Do not double the dose to catch up, as this can cause dangerous electrolyte spikes. Your procedure may need to be rescheduled if the prep is not completed correctly.
An overdose of Sodium Phosphate, Dibasic can be life-threatening. Symptoms include severe muscle cramping, tetany (uncontrolled muscle contractions), seizures, heart palpitations, and extreme thirst. In the event of a suspected overdose, call 911 or your local poison control center immediately. Treatment usually involves intravenous fluids and medications to lower phosphate and raise calcium levels.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or the timing of your dose without direct medical guidance.
Most patients taking Sodium Phosphate, Dibasic for bowel preparation will experience some level of gastrointestinal discomfort. These symptoms are generally expected due to the drug's mechanism of action:
> Warning: Stop taking Sodium Phosphate, Dibasic and call your doctor immediately or seek emergency care if you experience any of the following:
Sodium Phosphate, Dibasic is typically used for short-term indications. However, repeated use (such as chronic laxative abuse) can lead to:
The FDA has issued a Black Box Warning for oral sodium phosphate products used for bowel cleansing. The warning highlights the risk of Acute Phosphate Nephropathy, a form of acute kidney injury caused by the deposition of calcium phosphate crystals in the renal tubules. This condition can lead to permanent loss of kidney function and the need for long-term dialysis. Risk factors include age over 55, dehydration, history of kidney disease, and the use of certain medications like ACE inhibitors or NSAIDs.
Report any unusual symptoms, especially changes in urinary output or heart rhythm, to your healthcare provider immediately.
Sodium Phosphate, Dibasic is a potent medication that requires careful medical oversight. It is not a 'simple' laxative; the rapid shifts in fluid and electrolytes it induces can be dangerous for patients with underlying health conditions. The most critical safety requirement is maintaining aggressive hydration. Patients must be able to consume and retain large volumes of clear liquids to mitigate the risk of kidney damage and severe dehydration.
Healthcare providers typically order the following tests before and after administration of high-dose sodium phosphate:
Patients should avoid driving or operating heavy machinery for at least 24 hours after taking a bowel prep dose. The risk of sudden dizziness, fainting, or the urgent need for bowel movements makes these activities unsafe.
Alcohol should be strictly avoided while taking Sodium Phosphate, Dibasic. Alcohol is a diuretic that increases dehydration and can worsen electrolyte imbalances, significantly increasing the risk of kidney injury.
For bowel preparation, the medication is a one-time or two-time dose. If used as a supplement, do not stop taking it without consulting your doctor, as phosphate levels may crash, leading to muscle weakness and respiratory failure.
> Important: Discuss all your medical conditions, especially kidney, heart, or bowel problems, with your healthcare provider before starting Sodium Phosphate, Dibasic, Unspecified Form.
For each major interaction, the primary mechanism is usually either a pharmacodynamic effect (compounding the stress on the kidneys) or a physical interaction (binding in the gut). Management typically involves temporary discontinuation of blood pressure medications or NSAIDs 24-48 hours before the procedure, under a doctor's supervision.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter pain relievers.
Sodium Phosphate, Dibasic must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
There is a high degree of cross-sensitivity between different phosphate salts (monobasic, dibasic, and potassium phosphate). If you have had a reaction to one, you are likely to react to the others.
> Important: Your healthcare provider will evaluate your complete medical history, including recent blood work, before prescribing Sodium Phosphate, Dibasic.
Sodium Phosphate, Dibasic is classified as FDA Pregnancy Category C. There are no adequate, well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The primary concern is the risk of maternal dehydration and electrolyte shifts, which can affect placental perfusion. Most gastroenterologists prefer PEG-based solutions for pregnant patients as they are not absorbed.
It is known that phosphate is excreted in human milk. However, when used as a one-time dose for bowel prep, the amount reaching the infant is likely minimal. Nevertheless, because of the potential for serious adverse reactions in nursing infants from electrolyte shifts, a decision should be made whether to discontinue nursing for 24 hours or to avoid the drug.
Safety and effectiveness in pediatric patients under age 18 have not been established for bowel cleansing. Reports of fatalities in children following the use of sodium phosphate enemas or oral solutions have occurred, usually due to severe hyperphosphatemia and hypocalcemia. Pediatric use is generally restricted to specialized hospital settings for electrolyte replacement.
Patients over 65 are at the highest risk for complications. Clinical trials have shown that elderly patients have a higher incidence of serious adverse events, including renal failure and arrhythmias. Physicians often recommend 'split-dose' regimens or alternative products for this population to ensure safety.
In patients with any degree of renal insufficiency, the kidneys cannot effectively excrete the phosphate load. This leads to a rapid rise in serum phosphorus, which then binds to calcium, depositing as crystals in the kidneys (nephrocalcinosis). This medication is strictly avoided in moderate-to-severe kidney disease.
While the liver does not process the drug, patients with advanced liver disease (Child-Pugh Class B or C) often have 'third-spacing' of fluids (ascites). The osmotic pull of sodium phosphate can dangerously deplete the intravascular volume in these patients.
> Important: Special populations require individualized medical assessment and often require alternative medications for bowel cleansing.
Sodium Phosphate, Dibasic acts as a saline osmotic laxative. In the intestinal lumen, the dibasic phosphate ions ($HPO_4^{2-}$) are only partially absorbed. This creates a high osmotic pressure that prevents the absorption of water and actually draws water from the interstitial space into the gut. This results in a significant increase in liquid stool volume, which mechanically stimulates the colon to evacuate. In the blood, it provides inorganic phosphorus, which is taken up by cells via sodium-phosphate cotransporters (NPT2a and NPT2c) to be used in phosphorylation reactions and ATP synthesis.
The onset of action for the laxative effect is typically 30 minutes to 3 hours after oral administration and 2 to 5 minutes after rectal administration. The duration of effect lasts until the bowel is cleared, usually 6 to 12 hours. The dose-response relationship is steep; small increases in dose can lead to much larger shifts in fluid and electrolytes.
| Parameter | Value |
|---|---|
| Bioavailability | 40% - 70% (as phosphate) |
| Protein Binding | Negligible |
| Half-life | 4 - 8 hours (in healthy renal function) |
| Tmax | 1 - 3 hours |
| Metabolism | None (Inorganic salt) |
| Excretion | Renal (>90%) |
It is categorized as a Saline Laxative and an Electrolyte Replenisher. It is related to other phosphate salts like Sodium Phosphate Monobasic and Potassium Phosphate.
Common questions about Sunmark Saline Single
Sodium Phosphate, Dibasic is primarily used as a powerful osmotic laxative to clear the bowels before medical procedures like a colonoscopy. It works by drawing water into the intestines, which triggers a flushing effect to remove fecal matter. Additionally, it is used as a supplement to treat hypophosphatemia, which is a condition characterized by dangerously low levels of phosphorus in the blood. In some cases, it may also be used to help prevent certain types of kidney stones by acidifying the urine. Because of its potency, it is only used under the guidance of a healthcare professional.
The most common side effects include nausea, abdominal bloating, stomach cramping, and dizziness. These symptoms occur because the medication causes a rapid shift of water into the digestive tract, which can be physically taxing. Most patients will also experience frequent, watery bowel movements, which is the intended effect of the drug. While these are common, they can lead to dehydration if you do not drink enough clear liquids. If vomiting occurs and you cannot keep the medication down, you should contact your doctor immediately.
No, you should strictly avoid alcohol while taking this medication. Alcohol is a diuretic, meaning it encourages your body to lose more water through urination, which compounds the dehydrating effects of the sodium phosphate. This combination significantly increases your risk of developing acute kidney injury or severe electrolyte imbalances. Furthermore, alcohol can irritate the stomach lining, potentially worsening the nausea and cramping caused by the laxative. It is safest to wait at least 24 to 48 hours after your procedure before consuming alcohol.
Sodium Phosphate, Dibasic is generally not the first choice for pregnant women and is classified as Category C by the FDA. While there is no definitive evidence of birth defects, the drug causes significant fluid and electrolyte shifts that could potentially affect blood flow to the placenta. Dehydration is a major concern during pregnancy, as it can lead to complications like preterm labor. Most doctors prefer to use safer alternatives, such as polyethylene glycol (PEG), which is not absorbed into the bloodstream. Always consult your obstetrician before taking any bowel preparation medication.
When taken orally for bowel preparation, the medication typically begins to produce bowel movements within 30 minutes to 3 hours. However, the exact timing can vary based on your individual metabolism and when you last ate. You should stay close to a bathroom once you begin the regimen, as the urge to go can be sudden and intense. The 'flushing' process usually continues for several hours until the colon is completely empty. If you have not had a bowel movement within 6 hours of taking the dose, you should call your healthcare provider for further instructions.
For bowel preparation, the medication is usually only taken for one or two doses, so 'stopping' is not typically an issue. However, if you are taking it as a daily supplement for low phosphorus, you should never stop suddenly without medical advice. Abruptly stopping a phosphate supplement can cause your blood phosphorus levels to drop rapidly, leading to severe muscle weakness, confusion, and even respiratory failure. If you are experiencing side effects that make you want to stop, contact your doctor to discuss a safe tapering schedule or an alternative treatment.
If you miss a dose during your colonoscopy prep, contact your doctor's office or the endoscopy center immediately. The success of your procedure depends on a completely clear colon, and a missed dose may mean the doctor cannot see the intestinal wall clearly. Do not take a double dose to make up for the missed one, as this can cause a dangerous spike in sodium and phosphate levels. Your medical team will advise you on whether to take the missed dose later or if the procedure needs to be rescheduled. Follow their instructions exactly to ensure your safety.
No, Sodium Phosphate, Dibasic does not cause weight gain; in fact, it often causes temporary weight loss. Because it is a potent laxative that removes a large volume of water and waste from the body, most patients will see a lower number on the scale immediately after use. This is 'water weight' and is not a reflection of fat loss. Once you resume normal eating and drinking after your procedure, your weight will typically return to its baseline. It should never be used as a weight-loss aid, as this is extremely dangerous and can lead to permanent kidney damage.
Sodium Phosphate, Dibasic has several significant drug interactions that must be managed carefully. It can be particularly dangerous when taken with blood pressure medications like ACE inhibitors (e.g., lisinopril) or diuretics, as these increase the risk of kidney failure. Common over-the-counter pain relievers like ibuprofen (Advil) also increase this risk. Additionally, because it speeds up the digestive tract, it can prevent other oral medications from being absorbed properly. You must provide your doctor with a full list of all your current medications before starting this drug.
Yes, Sodium Phosphate, Dibasic is available in several generic forms, both as a standalone ingredient and in combination with other phosphate salts. Generic versions are typically much less expensive than brand-name products like OsmoPrep or Fleet Enemas. These generic formulations are required by the FDA to have the same active ingredients and provide the same clinical effect as the brand-name versions. However, always ensure you are purchasing the exact formulation (oral vs. rectal) that your doctor has recommended, as they are not interchangeable.
Other drugs with the same active ingredient (Sodium Phosphate, Dibasic, Unspecified Form)